Skip to main content

Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users

Basic Details
Date Posted
Status
Complete
Medical Product
carbidopa/levodopa
carbidopa/levodopa/entacapone (Stalevo)
entacapone
Description

This report investigates acute myocardial infarction (AMI) and stroke among users of entacapone, combination carbidopa/levodopa, and combination carbidopa/levodopa/entacapone (Stalevo) with Parkinson’s Disease in the Mini-Sentinel Distributed Database (MSDD). The package was distributed to Partners on February 24, 2011.

Deliverables (1)
Mini-Sentinel Modular Program Report: Risk of Acute Myocardial Infarction and Stroke among Carbidopa/Levodopa, Entacapone, and Carbidopa/Levodopa/Entacapone Users
Additional Details
FDA Center
CDER
Time Period
January 1, 2000 - December 31, 2010
Analysis Type
Mini-Sentinel
Population / Cohort
All individuals with Parkinson's DIsease
Data Sources
Mini-Sentinel Distributed Database (MSDD)